Systemic de-methylating treatment for invasive HPV-related cancers
We are planning a clinical study to determine safety, tolerability and first efficacy data of i.v. administered de-methylating treatment in patients with HPV-related invasive carcinomas in the anogenital and head and neck region.
![viren](http://atb-heidelberg.de/wp-content/uploads/2018/03/viren.jpg)